Deconstructing the ISTH hemophilia guidelines for the clinician

Guy Young1, Riitta Lassila2, Jane Mason3

  • 1Cancer and Blood Disorders Institute, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California, USA.

Insights

The International Society on Thrombosis and Haemostasis (ISTH) released new hemophilia guidelines, but many recommendations are conditional. This analysis offers clinicians more concrete guidance for managing hemophilia patients.

Area of Science:

  • Hematology
  • Clinical Guidelines
  • Rare Diseases

Background:

  • The International Society on Thrombosis and Haemostasis (ISTH) recently published comprehensive hemophilia guidelines.
  • These guidelines, while valuable, present numerous conditional recommendations, offering limited concrete direction for clinicians.
  • The reliance on the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology for a rare disease like hemophilia contributes to the conditional nature of the recommendations.

Purpose of the Study:

  • To deconstruct the ISTH hemophilia guidelines and provide clinicians with more actionable recommendations.
  • To supplement the ISTH guidelines with recent literature and expert clinical experience.
  • To offer a clearer path forward for managing patients with hemophilia.

Main Methods:

  • Critical analysis of the published ISTH Hemophilia Guidelines.
  • Integration of recent scientific literature relevant to hemophilia management.
  • Incorporation of extensive clinical experience from managing diverse hemophilia patient populations.

Main Results:

  • Identified that 11 out of 13 ISTH recommendations are conditional, requiring individual clinical judgment.
  • Developed a supplementary framework to provide more definitive management strategies.
  • Synthesized current evidence and expert opinion to address ambiguities in the guidelines.

Conclusions:

  • The ISTH guidelines require further interpretation to provide practical clinical application.
  • Clinicians need supplementary resources to navigate the conditional nature of hemophilia treatment recommendations.
  • This work offers a more concrete approach to hemophilia patient care, balancing guidelines with real-world experience and evidence.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
623
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
710
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.7K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.6K